Astiva Health, a fast-growing Medicare Advantage Prescription Drug (“MAPD”) health plan dedicated to reshaping personalized and comprehensive healthcare, has announced strategic expansions into three Southern California counties: Los Angeles, Riverside and San Bernardino. The expansion, which the company called a “milestone” in its commitment to broadening access to quality healthcare, is effective Jan. 1, 2024; the company has already started enrolling members in these locations. According to the announcement, Astiva Health anticipates substantial growth in Medicare Advantage enrollment across these regions, noting that the cumulative effect of this expansion will increase the total target Medicare beneficiaries by approximately 259%. Astiva Health is committed to providing transformative healthcare experiences tailored to meet specific needs of diverse communities, and as part of its expansion initiative, the company is focused on providing a more extensive network of care and fostering lasting relationships. “We are thrilled to bring Astiva Health’s transformative healthcare services to the residents of Los Angeles, Riverside and San Bernardino,” said Astiva Health cofounder and CEO Dr. Tri T. Nguyen in the press release. “This expansion not only allows us to serve more individuals but also underscores our commitment to making a meaningful impact on the well-being of diverse communities.”
To view the full press release, visit https://ibn.fm/Eqao5
About Astiva Health
Astiva Health is a fast-growing MAPD health plan committed to redefining the standards of personalized and comprehensive healthcare. With a mission to elevate the well-being of individuals, Astiva Health specializes in innovative health plans tailored to meet the unique requirements of its members. The organization prioritizes a culturally responsive approach to healthcare, offering multilingual solutions for customer service, marketing materials and educational resources. Astiva Health’s dedication to serving the underserved population is not only fulfilling a critical societal need but also positioning the company to tap into a market segment with significant growth potential. By addressing the diverse healthcare needs of its members, Astiva Health aims to create lasting relationships and contribute to the overall well-being of the communities it serves. Astiva Health invites individuals to join its transformative healthcare experience, where personalized care and lasting well-being take center stage. For more information about the company, visit www.AstivaHealth.com.
About BioMedWire
BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed)and Life Sciences sectors. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.
BMW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer
BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is powered by IBN